Clearwater Analytics Holdings Inc (NYSE:CWAN) reported that its Chief Financial Officer, James S. Cox, sold 18,700 shares of the company's Class A common stock on March 16, 2026. The sales were completed in two separate tranches and produced combined proceeds of roughly $436,354.
The first tranche accounted for 13,700 shares sold at a weighted average price of $23.321, amounting to $319,497. Transaction prices within that block ranged from $23.27 to $23.44. A second block of 5,000 shares was sold at a weighted average of $23.3715, generating $116,857, with execution prices between $23.29 and $23.43. Those trade prices align closely with the then-current quoted stock price of $23.38.
On the same date, Cox exercised options to acquire 37,235 shares of Class A common stock at an exercise price of $4.40 per share. The exercise represented a cash outlay of $163,834. In connection with the option exercise, 23,535 of the acquired shares were surrendered to cover tax withholding obligations, based on a price of $23.321 per share and a total value of $548,859 for those withheld shares.
After completing these transactions, Cox's direct ownership in Clearwater Analytics stands at 469,114 shares. The company's market valuation is reported at $6.92 billion, and it retains a financial health score characterized as "GOOD." Clearwater Analytics also recorded robust revenue growth of 62% over the last twelve months.
Market analysts and proprietary research have reacted to Clearwater's recent developments. An InvestingPro analysis cited in company disclosures indicates the stock was trading above its Fair Value estimate at the time of the transactions. Separately, several major brokerages adjusted their ratings following company disclosures tied to its strategic outlook and pending transaction activity.
Specifically, RBC Capital downgraded Clearwater Analytics from Outperform to Sector Perform, pointing to the filing of a proxy statement that included merger-related financial projections. Morgan Stanley moved its rating from Overweight to Equalweight, while UBS shifted from Buy to Neutral; both firms made their changes after the announcement of an acquisition agreement that involves an investor group led by Permira and Warburg Pincus.
Alongside those market and rating developments, Clearwater Analytics secured a multi-year mandate with Generali Deutschland to manage its €40 billion unit-linked fund life insurance business. The agreement is intended to standardize and enhance portfolio management processes for that unit-linked business.
These events - insider share sales coupled with option exercises, analyst rating downgrades tied to merger disclosures, and a significant institutional client win - mark a period of active corporate and market activity for Clearwater Analytics.
Key points
- James S. Cox sold 18,700 Class A shares on March 16, 2026, in two tranches for approximately $436,354 in total.
- Cox exercised options to acquire 37,235 shares at $4.40 per share and used 23,535 shares to satisfy tax-withholding obligations.
- Clearwater Analytics faces analyst rating changes amid an acquisition agreement led by Permira and Warburg Pincus and concurrently secured a multi-year Generali Deutschland mandate covering €40 billion in unit-linked assets.
Risks and uncertainties
- Analyst downgrades from RBC Capital, Morgan Stanley and UBS may reflect investor uncertainty around merger-related disclosures and projected financials; this affects market sentiment in the software and financial services sectors.
- Insider sales concurrent with option exercises and tax withholding could be interpreted variably by investors and may introduce short-term trading volatility for the stock.
- Ongoing integration and execution risks tied to the announced acquisition and the Generali Deutschland mandate could influence near-term operational and revenue outcomes for Clearwater Analytics.